Study Of Single Dose Of ATN-103 Administered To Healthy Japanese Male Subjects
Clinical trial NCT00916110 · COMPLETED
Trial details
- NCT number
- NCT00916110
- Sponsor
- Ablynx, a Sanofi company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2008-11-01
- Primary completion
- 2009-11-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.